September 10, 2008Open Access

Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer

Key Points

Key points are not available for this paper at this time.

Abstract

As compared with platinum-based chemotherapy plus fluorouracil alone, cetuximab plus platinum-fluorouracil chemotherapy improved overall survival when given as first-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck. (ClinicalTrials.gov number, NCT00122460.)

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Authors

Jan B. Vermorken

Ricard Mesı́a

Fernando Rivera

Journals

New England Journal of Medicine

Actions

Institutions

Universität Hamburg

Ghent University Hospital

University Medical Center Hamburg-Eppendorf

References and Citations

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer

Key Points

Abstract

Citation Network

Connected Papers

Discussion

Authors

Journals

Actions

Institutions

References and Citations

Citation Network

Connected Papers

Discussion

Cite this study